ChemoCentryxis a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer. ChemoCentryx focuses on the discovery, development, and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors. The company's small molecule product candidates are designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of ChemoCentryx Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. ChemoCentryx Inc market cap is $3.71B.
What is the 52-week high for ChemoCentryx Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. ChemoCentryx Inc 52 week high is $52.00 as of September 07, 2025.
What is the 52-week low for ChemoCentryx Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. ChemoCentryx Inc 52 week low is $14.95 as of September 07, 2025.
What is ChemoCentryx Inc stock price today?
ChemoCentryx Inc stock price today is $51.99.
What was ChemoCentryx Inc stock price yesterday?
ChemoCentryx Inc stock price yesterday was $51.96.
What is the PE ratio of ChemoCentryx Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. ChemoCentryx Inc’s P/E ratio is -27.56.
What is the Price-to-Book ratio of ChemoCentryx Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. ChemoCentryx Inc P/B ratio is 15.6808.
What is the 50-day moving average of ChemoCentryx Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. ChemoCentryx Inc 50-day moving average is $51.49.